Steven (Steve) C. Mizell is a member of the Board of Directors at Allegion and chair of the Compensation Committee.
Steve also serves on the Board of Directors at Group 1 Automotive, Inc. and Grail Inc. Steve previously served on the Board of Directors for Oshkosh Corporation, where he was chair of the Human Resources Committee.
Steve formerly served as executive vice president, chief human resources officer (CHRO) at Merck & Co., Inc. (2018 to 2024) and was responsible for all aspects of human resources for over 68,000 employees worldwide. Steve joined Merck in 2018 from Monsanto, where he was responsible for creating an industry-leading workplace for more than 20,000 employees around the world. In this role, he oversaw the company’s approach to talent acquisition and development, employee wellness as well as diversity and inclusion.
Steve joined Monsanto as senior vice president, human resources, in 2004 and served as executive vice president, human resources, from 2007 to 2018. Previously, he served as senior vice president and chief corporate resources officer for AdvancePCS, a pharmaceutical company, and he also held key human resources management roles at companies across the energy, defense, beverage and technology sectors.
Over the course of his career at Monsanto, Steve’s leadership has helped the company earn recognition as a best place to work. Most recently, this has included being named among World’s Best Multinational Workplaces by Great Place to Work®; 100 Best Adoption-Friendly Workplaces by the Dave Thomas Foundation for Adoption; Top 50 Companies for Diversity by DiversityInc; and as a Top Employer by Science Magazine.
A resident of St. Louis, Missouri, Steve is actively involved in a number of community causes. He currently serves on the Board of Directors for Opera Theater St. Louis and is a supporter of the U.S. Kidney Foundation, Habitat for Humanity and Youth in Need. He has been recognized by the St. Louis Business Journal as one of St. Louis’s Most Influential Diverse Business Leaders.
Steve holds a B.S. from Georgia Institute of Technology and an M.S. in Management from Carnegie Mellon University.
What is Steven Mizell's net worth?
The estimated net worth of Steven Mizell is at least $797.89 thousand as of February 19th, 2026. Mizell owns 4,915 shares of Allegion stock worth more than $797,886 as of February 20th. This net worth approximation does not reflect any other investments that Mizell may own. Learn More about Steven Mizell's net worth.
How do I contact Steven Mizell?
Has Steven Mizell been buying or selling shares of Allegion?
Within the last three months, Steven Mizell has sold $227,026.00 in shares of Allegion stock. Most recently, Steven Mizell sold 1,000 shares of the business's stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $161.51, for a transaction totalling $161,510.00. Following the completion of the sale, the director now directly owns 4,915 shares of the company's stock, valued at $793,821.65. Learn More on Steven Mizell's trading history.
Who are Allegion's active insiders?
Allegion's insider roster includes Jeffrey Braun (SVP), Timothy Eckersley (VP), Jennifer Hawes (SVP), David Ilardi (SVP), Tracy Kemp (SVP), Robert Martens (SVP), Steven Mizell (Director), Nickolas Musial (CAO), David Petratis (CEO), Douglas Ranck (CAO), Gregg Sengstack (Director), Gregg Sengstack (Director), Patrick Shannon (CFO), and John Stone (President, CEO & Director). Learn More on Allegion's active insiders.
Are insiders buying or selling shares of Allegion?
During the last twelve months, insiders at the scientific and technical instruments company sold shares 6 times. They sold a total of 18,880 shares worth more than $2,999,240.28. The most recent insider tranaction occured on February, 19th when Director Steven Mizell sold 1,000 shares worth more than $161,510.00. Insiders at Allegion own 0.2% of the company.
Learn More about insider trades at Allegion. Information on this page was last updated on 2/19/2026.
